Monivent Investor Relations Material
Latest events
Q1 2025
20 May, 2025
Q4 2024
28 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Monivent
Access all reports
Monivent develops and provides medical devices designed to support neonatal respiratory care. The company focuses on creating innovative solutions that assist healthcare professionals in monitoring and optimizing ventilation for newborns. Its technologies aim to improve patient outcomes by enhancing precision and safety in critical care settings. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the Nasdaq Stockholm.
)
)
)